27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc. (NYSE:PFE). Merck disappointed by lowering its outlook, although sell-side stayed positive on the prospects.
Presentations at the American Association of Cancer Research Virtual Conference created some volatility. Verastem Inc (NASDAQ:VSTM) became a casualty of "not-so-impressive" clinical data on its Phase 1 asset VS-6766 that targets KRAS mutant advanced solid tumors. The stock shed about 57% to a low of $1.77 before recovering some lost ground.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Here are the key catalysts for the unfolding week.
Conferences
SunTrust Robinson Humphrey 6th Annual Life Sciences Summit (Virtual Conference): May 5–6
Maxim Group M-Vest Infectious Disease Virtual Conference: May 5
Related Link: A Deep Dive On Coronavirus Vaccine Plays Moderna, Inovio
Clinical Readouts
Adverum Biotechnologies Inc (NASDAQ:ADVM) is scheduled to present new data from the OPTIC Phase1 clinical trial of ADVM-022 intravitreal gene therapy in wet age-related macular degeneration. The call discussing the results is scheduled for Monday afternoon.
Auris Medical Holding Ltd (NASDAQ:EARS) is due to release top-line data from the completed Phase 1b AM-201 trial in early May. AM-201 is being evaluated in antipsychotic-induced weight gain.
Early Q2 Schedule
Ovid Therapeutics Inc (NASDAQ:OVID): Phase 2 top-line data for OV101 in Fragile X syndrome
Iterum Therapeutics PLC (NASDAQ:ITRM): Phase 3 data for Sulopenem in uncomplicated and complicated urinary tract infections
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
Enanta Pharmaceuticals Inc (NASDAQ:ENTA): data from our INTREPID study of EDP-305 in patients with primary biliary cholangitis
Earnings
Monday
• Marinus Pharmaceuticals Inc (NASDAQ:MRNS) (before the market open)
• Minerva Neurosciences Inc (NASDAQ:NERV) (before the market open)
• Epizyme Inc (NASDAQ:EPZM) (before the market open)
• SI-Bone Inc (NASDAQ:SIBN) (after the market close)
• Corcept Therapeutics Incorporated (NASDAQ:CORT) (after the market close)
• Chembio Diagnostics Inc (NASDAQ:CEMI) (after the market close)
• GenMark Diagnostics, Inc (NASDAQ:GNMK) (after the market close)
• Kura Oncology Inc (NASDAQ:KURA) (after the market close)
• Varian Medical Systems, Inc. (NYSE:VAR) (after the market close)
• Fulgent Genetics Inc (NASDAQ:FLGT) (after the market close)
See Also: Inovio Analysts Project About 24% Upside Potential Amid Optimism On Coronavirus DNA Vaccine
Tuesday
• Oxford Immunotec Global PLC (NASDAQ:OXFD) (before the market open)
• Karyopharm Therapeutics Inc (NASDAQ:KPTI) (before the market open)
• Haemonetics Corporation (NYSE:HAE) (before the market open)
• Antares Pharma Inc (NASDAQ:ATRS) (before the market open)
• Harvard Bioscience, Inc. (NASDAQ:HBIO) (before the market open)
• Vericel Corp (NASDAQ:VCEL) (before the market open)
• Regeneron Pharmaceuticals Inc (NASDAQ:REGN) (before the market open)
• Neuronetics Inc (NASDAQ:STIM) (before the market open)
• Mallinckrodt PLC (NYSE:MNK) (before the market open)
• Akebia Therapeutics Inc (NASDAQ:AKBA) (before the market open)
• Agile Therapeutics Inc (NASDAQ:AGRX) (after the market close)
• Aquestive Therapeutics Inc (NASDAQ:AQST) (after the market close)
• Akcea Therapeutics Inc (NASDAQ:AKCA) (after the market close)
• Acorda Therapeutics Inc (NASDAQ:ACOR) (after the market close)
• Axonics Modulation Technologies Inc (NASDAQ:AXNX) (after the market close)
• Synthetic Biologics Inc (NYSE:SYN) (after the market close)
• T2 Biosystems Inc (NASDAQ:TTOO) (after the market close)
• Iovance Biotherapeutics Inc (NASDAQ:IOVA) (after the market close)
• MacroGenics Inc (NASDAQ:MGNX) (after the market close)
• Zogenix, Inc. (NASDAQ:ZGNX) (after the market close)
• Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) (after the market close)
• Exelixis, Inc. (NASDAQ:EXEL) (after the market close)
• Myriad Genetics, Inc. (NASDAQ:MYGN) (after the market close)
• Inspire Medical Systems Inc (NYSE:INSP) (after the market close)
• Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) (after the market close)
• Supernus Pharmaceuticals Inc (NASDAQ:SUPN) (after the market close)
• Nevro Corp (NYSE:NVRO) (after the market close)
• Clovis Oncology Inc (NASDAQ:CLVS) (after the market close)
• InVitae Corp (NYSE:NVTA) (after the market close)
• Cytosorbents Corp (NASDAQ:CTSO) (after the market close)
• Cardiovascular Systems Inc (NASDAQ:CSII) (after the market close)
• Cerus Corporation (NASDAQ:CERS) (after the market close)
• Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) (after the market close)
• Incyte Corporation (NASDAQ:INCY) (after the market close)
• Orthopediatrics Corp (NASDAQ:KIDS) (after the market close)
Wednesday
• Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) (before the market open)
• Horizon Therapeutics PLC (NASDAQ:HZNP) (before the market open)
• Constellation Pharmaceuticals Inc (NASDAQ:CNST) (before the market open)
• Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) (before the market open)
• IVERIC bio Inc (NASDAQ:ISEE) (before the market open)
• Blueprint Medicines Corp (NASDAQ:BPMC) (before the market open)
• BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) (before the market open)
• Strongbridge Biopharma plc (NASDAQ:SBBP) (before the market open)
• Evofem Biosciences, Inc. (NASDAQ:EVFM) (before the market open)
• Neurocrine Biosciences, Inc. (NASDAQ:NBIX) (before the market open)
• Jounce Therapeutics Inc (NASDAQ:JNCE) (before the market open)
• PPD Inc (NASDAQ:PPD) (before the market open)
• Zoetis Inc (NYSE:ZTS) (before the market open)
• Ionis Pharmaceuticals Inc (NASDAQ:IONS) (before the market open)
• TherapeuticsMD Inc (NASDAQ:TXMD) (before the market open)
• Avanos Medical Inc (NYSE:AVNS) (before the market open)
• Aerie Pharmaceuticals Inc (NASDAQ:AERI) (after the close)
• Allogene Therapeutics Inc (NASDAQ:ALLO) (after the close)
• ADMA Biologics Inc (NASDAQ:ADMA) (after the close)
• Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) (after the close)
• AxoGen, Inc Common Stock (NASDAQ:AXGN) (after the close)
• Global Blood Therapeutics Inc (NASDAQ:GBT) (after the close)
• Pacific Biosciences of California (NASDAQ:PACB) (after the close)
• Theravance Biopharma Inc (NASDAQ:TBPH) (after the close)
• BioTelemetry Inc (NASDAQ:BEAT) (after the close)
• Bio-Rad Laboratories, Inc. (NYSE:BIO) (after the close)
• Veracyte Inc (NASDAQ:VCYT) (after the close)
• Ligand Pharmaceuticals Inc. (NASDAQ:LGND) (after the close)
• Precigen Inc (NASDAQ:PGEN) (after the close)
• Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) (after the close)
• OraSure Technologies, Inc. (NASDAQ:OSUR) (after the close)
• NuVasive, Inc. (NASDAQ:NUVA) (after the close)
• Sarepta Therapeutics Inc (NASDAQ:SRPT) (after the close)
• Natera Inc (NASDAQ:NTRA) (after the close)
• Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) (after the close)
• Qiagen NV (NYSE:QGEN) (after the close)
• Enanta Pharmaceuticals Inc (NASDAQ:ENTA) (after the close)
• Esperion Therapeutics Inc (NASDAQ:ESPR) (after the close)
• G1 Therapeutics Inc (NASDAQ:GTHX) (after the close)
• Quidel Corporation (NASDAQ:QDEL) (after the close)
• Cytokinetics, Inc. (NASDAQ:CYTK) (after the close)
• MannKind Corporation (NASDAQ:MNKD) (after the close)
Thursday
• Integra Lifesciences Holdings Corp (NASDAQ:IART) (before the market open)
• Intra-Cellular Therapies Inc (NASDAQ:ITCI) (before the market open)
• Endo International PLC (NASDAQ:ENDP) (before the market open)
• Xeris Pharmaceuticals Inc (NASDAQ:XERS) (before the market open)
• Moderna Inc (NASDAQ:MRNA) (before the market open)
• Syros Pharmaceuticals Inc (NASDAQ:SYRS) (before the market open)
• Elanco Animal Health Inc (NYSE:ELAN) (before the market open)
• Athenex Inc (NASDAQ:ATNX) (before the market open)
• Aldeyra Therapeutics Inc (NASDAQ:ALDX) (before the market open)
• Albireo Pharma Inc (NASDAQ:ALBO) (before the market open)
• ANI Pharmaceuticals Inc (NASDAQ:ANIP) (before the market open)
• Agenus Inc (NASDAQ:AGEN) (before the market open)
• Amicus Therapeutics, Inc. (NASDAQ:FOLD) (before the market open)
• Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) (before the market open)
• Bristol-Myers Squibb Co (NYSE:BMY) (before the market open)
• Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) (before the market open)
• X4 Pharmaceuticals Inc (NASDAQ:XFOR) (before the market open)
• Miragen Therapeutics Inc (NASDAQ:MGEN) (before the market open)
• Kala Pharmaceuticals Inc (NASDAQ:KALA) (before the market open)
• Seres Therapeutics Inc (NASDAQ:MCRB) (before the market open)
• Intellia Therapeutics Inc (NASDAQ:NTLA) (before the market open)
• Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) (before the market open)
• Editas Medicine Inc (NASDAQ:EDIT) (before the market open)
• Pacira Biosciences Inc (NASDAQ:PCRX) (before the market open)
• Syndax Pharmaceuticals Inc (NASDAQ:SNDX) (after the close)
• Tricida Inc (NASDAQ:TCDA) (after the close)
• Helius Medical Technologies Inc (NASDAQ:HSDT) (after the close)
• Twist Bioscience Corp (NASDAQ:TWST) (after the close)
• Athersys Inc (NASDAQ:ATHX) (after the close)
• Accelerate Diagnostics Inc (NASDAQ:AXDX) (after the close)
• Adamas Pharmaceuticals Inc (NASDAQ:ADMS) (after the close)
• Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) (after the close)
• Anika Therapeutics Inc (NASDAQ:ANIK) (after the close)
• Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) (after the close)
• ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) (after the close)
• Calithera Biosciences Inc (NASDAQ:CALA) (after the close)
• BioDelivery Sciences International, Inc. (NASDAQ:BDSI) (after the close)
• Puma Biotechnology Inc (NASDAQ:PBYI) (after the close)
• Coherus Biosciences Inc (NASDAQ:CHRS) (after the close)
• Kindred Biosciences Inc (NASDAQ:KIN) (after the close)
• PDL BioPharma Inc (NASDAQ:PDLI) (after the close)
• Rockwell Medical Inc (NASDAQ:RMTI) (after the close)
• Penumbra Inc (NYSE:PEN) (after the close)
• Pfenex Inc (NYSE:PFNX) (after the close)
• ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) (after the close)
• NovaBay Pharmaceuticals, Inc. (NYSE:NBY) (after the close)
• ICU Medical Inc (NASDAQ:ICUI) (after the close)
• Nektar Therapeutics (NASDAQ:NKTR) (after the close)
• Savara Inc (NASDAQ:SVRA) (after the close)
• Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) (after the close)
• OptiNose Inc (NASDAQ:OPTN) (after the close)
• Eloxx Pharmaceuticals Inc (NASDAQ:ELOX) (after the close)
• Five Prime Therapeutics Inc (NASDAQ:FPRX) (after the close)
• Flexion Therapeutics Inc (NASDAQ:FLXN) (after the close)
• FibroGen Inc (NASDAQ:FGEN) (after the close)
• Globus Medical Inc (NYSE:GMED) (after the close)
• Guardant Health Inc (NASDAQ:GH) (after the close)
• OpGen Inc (NASDAQ:OPGN) (after the close)
• Lineage Cell Therapeutics Inc (NYSE:LCTX) (after the close)
• Dynavax Technologies Corporation (NASDAQ:DVAX) (after the close)
• Chiasma Inc (NASDAQ:CHMA) (after the close)
• Collegium Pharmaceutical Inc (NASDAQ:COLL) (after the close)
• Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) (after the close)
• Caladrius Biosciences Inc (NASDAQ:CLBS) (after the close)
• Glaukos Corp (NYSE:GKOS) (after the close)
• Celcuity Inc (NASDAQ:CELC) (after the close)
• Codexis, Inc. (NASDAQ:CDXS) (after the close)
• CytomX Therapeutics Inc (NASDAQ:CTMX) (after the close)
• Insulet Corporation (NASDAQ:PODD) (after the close)
Friday
• Meridian Bioscience, Inc. (NASDAQ:VIVO) (before the market open)
• Mersana Therapeutics Inc (NASDAQ:MRSN) (before the market open)
• Ocular Therapeutix Inc (NASDAQ:OCUL) (before the market open)
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.